Literature DB >> 22528941

EphB4 is overexpressed in papillary thyroid carcinoma and promotes the migration of papillary thyroid cancer cells.

Wang Xuqing1, Cui Lei, Mao Zhengfa, Dang Shengchun, Fan Xin, Qu Jianguo, Zhang Jianxin.   

Abstract

EphB4 tyrosine kinase receptor has been involved in various physiologic and pathologic processes, and the role of the EphB4 in tumorigenesis has recently attracted much interest. However, its function in papillary thyroid carcinoma remains poorly understood. In this study, we explored the function of EphB4 in papillary thyroid carcinoma. We found that the expression of EphB4 was significantly upregulated in clinical samples. Overexpression of EphB4 in papillary thyroid carcinoma cell lines accelerated cell migration. In contrast, downregulation of EphB4 inhibited cell migration and suppressed in vivo tumor metastasis. Furthermore, we showed that EphB4 promoted cell migration by inhibiting the phosphorylation of FAK and paxillin. Moreover, EphB4 promoted cell migration in a kinase-independent manner. Taken together, our findings suggest that EphB4 plays an important role in the progression of papillary thyroid carcinoma by stimulating cell migration and EphB4 might be a potential therapeutic target in papillary thyroid carcinoma.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22528941     DOI: 10.1007/s13277-012-0392-5

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  25 in total

Review 1.  Mechanisms and functions of Eph and ephrin signalling.

Authors:  Klas Kullander; Rüdiger Klein
Journal:  Nat Rev Mol Cell Biol       Date:  2002-07       Impact factor: 94.444

2.  Receptor tyrosine kinase EphB4 is a survival factor in breast cancer.

Authors:  S Ram Kumar; Jasbir Singh; Guangbin Xia; Valery Krasnoperov; Loubna Hassanieh; Eric J Ley; Jeffrey Scehnet; Neil G Kumar; Debra Hawes; Michael F Press; Fred A Weaver; Parkash S Gill
Journal:  Am J Pathol       Date:  2006-07       Impact factor: 4.307

3.  EphB4 expression and biological significance in prostate cancer.

Authors:  Guangbin Xia; S Ram Kumar; Rizwan Masood; Sutao Zhu; Ramchandra Reddy; Valery Krasnoperov; David I Quinn; Susan M Henshall; Robert L Sutherland; Jacek K Pinski; Siamak Daneshmand; Maurizio Buscarini; John P Stein; Chen Zhong; Daniel Broek; Pradip Roy-Burman; Parkash S Gill
Journal:  Cancer Res       Date:  2005-06-01       Impact factor: 12.701

4.  The EphB4 receptor-tyrosine kinase promotes the migration of melanoma cells through Rho-mediated actin cytoskeleton reorganization.

Authors:  Nai-Ying Yang; Elena B Pasquale; Laurie B Owen; Iryna M Ethell
Journal:  J Biol Chem       Date:  2006-08-31       Impact factor: 5.157

5.  The receptor tyrosine kinase EphA2 promotes mammary adenocarcinoma tumorigenesis and metastatic progression in mice by amplifying ErbB2 signaling.

Authors:  Dana M Brantley-Sieders; Guanglei Zhuang; Donna Hicks; Wei Bin Fang; Yoonha Hwang; Justin M M Cates; Karen Coffman; Dowdy Jackson; Elizabeth Bruckheimer; Rebecca S Muraoka-Cook; Jin Chen
Journal:  J Clin Invest       Date:  2008-01       Impact factor: 14.808

6.  Regulation of uptake of 18F-FDG by a follicular human thyroid cancer cell line with mutation-activated K-ras.

Authors:  Olaf Prante; Simone Maschauer; Valerie Fremont; Julia Reinfelder; Robert Stoehr; Mariusz Szkudlinski; Bruce Weintraub; Arndt Hartmann; Torsten Kuwert
Journal:  J Nucl Med       Date:  2009-08       Impact factor: 10.057

7.  Interplay between EphB4 on tumor cells and vascular ephrin-B2 regulates tumor growth.

Authors:  Nicole K Noren; Mark Lu; Andrew L Freeman; Mitchell Koolpe; Elena B Pasquale
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-05       Impact factor: 11.205

8.  Expression of connective tissue growth factor in tumor tissues is an independent predictor of poor prognosis in patients with gastric cancer.

Authors:  Lu-Ying Liu; Yan-Chun Han; Shu-Hua Wu; Zeng-Hua Lv
Journal:  World J Gastroenterol       Date:  2008-04-07       Impact factor: 5.742

9.  Epidermal growth factor stimulates cell proliferation and inhibits iodide uptake of FRTL-5 cells in vitro.

Authors:  L M Asmis; H Gerber; J Kaempf; H Studer
Journal:  J Endocrinol       Date:  1995-06       Impact factor: 4.286

10.  Increasing thyroid cancer incidence in Canada, 1970-1996: time trends and age-period-cohort effects.

Authors:  S Liu; R Semenciw; A M Ugnat; Y Mao
Journal:  Br J Cancer       Date:  2001-11-02       Impact factor: 7.640

View more
  2 in total

1.  Clinical Significance of EphB4 and EphB6 Expression in Human Malignant and Benign Thyroid Lesions.

Authors:  Constantinos Giaginis; Paraskevi Alexandrou; Elpida Poulaki; Ioanna Delladetsima; Constantinos Troungos; Efstratios Patsouris; Stamatios Theocharis
Journal:  Pathol Oncol Res       Date:  2015-07-30       Impact factor: 3.201

2.  Novel EPHB4 Receptor Tyrosine Kinase Mutations and Kinomic Pathway Analysis in Lung Cancer.

Authors:  Benjamin D Ferguson; Yi-Hung Carol Tan; Rajani S Kanteti; Ren Liu; Matthew J Gayed; Everett E Vokes; Mark K Ferguson; A John Iafrate; Parkash S Gill; Ravi Salgia
Journal:  Sci Rep       Date:  2015-06-15       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.